Literature DB >> 14762841

Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview.

Daniel Jaeck1, Philippe Bachellier, Elie Oussoultzoglou, Jean-Christophe Weber, Philippe Wolf.   

Abstract

A multicenter retrospective review of 1467 patients treated by liver resection (LR) for hepatocellular carcinoma (HCC) in Europe over a 13-year period showed a mean mortality rate of 10.6%, which was correlated with the extent of LR, the etiology of cirrhosis and the study period with an improvement during the last years. Improved 5-year overall survival (20-51%) and disease-free survival (20-33%) reached similar rates in cirrhotic than in non-cirrhotic patients. Overall results were similar to those reported in Asian series as far as patients and tumor characteristics were comparable.

Entities:  

Mesh:

Year:  2004        PMID: 14762841     DOI: 10.1002/lt.20041

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  29 in total

Review 1.  Post-hepatectomy liver failure.

Authors:  Rondi Kauffmann; Yuman Fong
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

Review 2.  Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Authors:  Karen E Bremner; Ahmed M Bayoumi; Morris Sherman; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

3.  Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?

Authors:  Theodoros Michelakos; Dimitrios Xourafas; Motaz Qadan; Rafael Pieretti-Vanmarcke; Lei Cai; Madhukar S Patel; Joel T Adler; Fermin Fontan; Usama Basit; Parsia A Vagefi; Nahel Elias; Kenneth K Tanabe; David Berger; Heidi Yeh; James F Markmann; David C Chang; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2018-09-14       Impact factor: 3.452

4.  Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV.

Authors:  Di-Peng Ou; Lian-Yue Yang; Geng-Wen Huang; Yi-Ming Tao; Xiang Ding; Zhi-Gang Chang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

5.  Portal hypertension: contraindication to liver surgery?

Authors:  Lorenzo Capussotti; Alessandro Ferrero; Luca Viganò; Andrea Muratore; Roberto Polastri; Hedayat Bouzari
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

6.  Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.

Authors:  Junhao Zheng; Xu Feng; Yuelong Liang; Jingwei Cai; Zhaoqi Shi; Mubarak Ali Kirih; Liye Tao; Xiao Liang
Journal:  Surg Endosc       Date:  2020-07-06       Impact factor: 4.584

7.  Randomized Trial of Spheroid Reservoir Bioartificial Liver in Porcine Model of Posthepatectomy Liver Failure.

Authors:  Harvey S Chen; Dong Jin Joo; Mohammed Shaheen; Yi Li; Yujia Wang; Jian Yang; Clara T Nicolas; Kelly Predmore; Bruce Amiot; Gregory Michalak; Taofic Mounajjed; Jeff Fidler; Walter K Kremers; Scott L Nyberg
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

8.  Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma.

Authors:  Peng Liu; Jia-Mei Yang; Wen-Yang Niu; Tong Kan; Feng Xie; Dian-Qi Li; Ye Wang; Yan-Ming Zhou
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

9.  Liver resective surgery: a multivariate analysis of postoperative outcome and complication.

Authors:  Enrico Benzoni; Alessandro Cojutti; Dario Lorenzin; Gian Luigi Adani; Umberto Baccarani; Alessandro Favero; Aron Zompicchiati; Fabrizio Bresadola; Alessandro Uzzau
Journal:  Langenbecks Arch Surg       Date:  2006-09-16       Impact factor: 3.445

10.  Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series.

Authors:  Y Patrice Le Treut; Jean Hardwigsen; Pascal Ananian; Jean Saïsse; Emilie Grégoire; Hubert Richa; Pierre Campan
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.